Navigation Links
Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority
Date:6/18/2013

Phoenix, AZ (PRWEB) June 18, 2013

Nasseo, Inc. today announces that it has been named the 2013 Innovation Challenge Winner out of hundreds of applicants by the Arizona Commerce Authority (ACA) in its spring Arizona Innovation Challenge. The Arizona Innovation Challenge (AIC) awards the most money in the country for a technology commercialization challenge, granting a financial award to what it deems to be the world’s most promising technology ventures. Nasseo’s state of the art dental and orthopedic implant surface modification technology captured the attention of the ACA this year. With this victory, Nasseo is honored to accept a $250,000 grant award to commercialize their first product, the TiArray™ Dental Implant.

In the ACA’s press release about the award, Nasseo was described as “inventive Arizona entrepreneurs who are creating technology solutions with potential global implications.” Nasseo is headquartered at the BioInspire Medtech incubator in Peoria, AZ which is sponsored by BioAccel who also invested $300K into the company as part of the seed round.

Nasseo’s medical innovation has resonated with audiences across industries. The company most recently won CONNECT’s Life Sciences Capital Competition earlier this year, earning it prestigious membership as a CONNECT Portfolio Company and the distinction as a “Rock Star of Innovation” by CONNECT. Prior to that, Nasseo had been invited to showcase its work at the 2012 World’s Best Technology (WBT) Innovation Marketplace and the 2013 National Innovation Showcase. And in its earliest victory, Nasseo made history at the UC San Diego (UCSD) Business Plan Competition, as the first startup to win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo says, “We appreciate AIC’s recognition of the urgency to commercialize our ground-breaking technology. Not only is this implant technology unique, but the implications are far-reaching. This award will offer a significant boost as we initiate production and sales of the Nasseo TiArray™ Dental Implant for patients in need.”

The company’s efforts to raise a $2M+ Series A investment round by the Fall of 2013 are also underway. Along with today’s award, the Series A funding will be used toward production and sales of the company’s TiArray™ Dental Implant to improve dental implant standards. The funding will also be used to develop a PEEK based spinal implant that integrates Nasseo’s same core implant surface modification technology.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art implant surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in Phoenix, AZ and San Diego, CA. For more information, please contact us at info(at)nasseo(dot)com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10846687.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nasseo Wins CONNECT Life Sciences Capital Competition and Joins CONNECT Portfolio
2. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
3. Neogen announces Bohannon retirement, successor named
4. SoundConnect Named Adobe Connect Channel Partner
5. Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
6. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
7. St. Jude scientist named Howard Hughes Medical Institute investigator
8. CellHealth Institute is Named 2013 Edison Award Winner
9. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
10. Street Named After EMCO High Voltage Corporation
11. Serial Entrepreneur Ken Malone Named BHI Entrepreneur-in-Residence to Offer Commercialization Guidance to Start-Ups Based on UM Discoveries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2019)... ... October 22, 2019 , ... nQ Medical, Inc. of Cambridge, MA, was ... Companies List which was announced at a showcase event yesterday in Los Angeles. nQ ... strong business plans, and impressive near-term growth projections to be named one of the ...
(Date:10/22/2019)... ... October 22, 2019 , ... DermBiont, ... its lead program, DBI-001, met its primary safety endpoints, with no application site ... clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). Additionally, the ...
(Date:10/15/2019)... , ... October 14, 2019 , ... ARPR , an award-winning tech PR agency ... honored as a Health Care Agency of the Year in the Ragan’s Health Care ... as a finalist by Ragan’s. The firm also revealed today that its healthIT practice group ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has added an ... 2019 in Las Vegas with spots still open. , The speaker, Dr. Ian White ... League universities including Cornell, Harvard and Dartmouth. He currently serves as the Chief Scientific ...
Breaking Biology Technology:
(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now ... the rest of 2019. The code to use during checkout is FIFTYOFF and applies ... is the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures ...
(Date:11/5/2019)... ... November 05, 2019 , ... Catalent, ... drugs, biologics, gene therapies, and consumer health products, today announced it will present ... Barcelona, Spain on Nov. 12 – 14, 2019. , On Wednesday, Nov. 13 ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine Standards ... analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, evaluate ... , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal ...
Breaking Biology News(10 mins):